The Errand That Rode in the Passenger Seat
You remember the errand. You carry it with you. Somehow, it still doesn’t get done.
Research
Research
Research
Wellness
Research
Recovery
Research
Aging
Research
Research
Research
Research
You remember the errand. You carry it with you. Somehow, it still doesn’t get done.
An October 30 federal notice names six peptide substances for conditional compounding enforcement discretion. It does not approve those d…
Compare the batch records, testing scope and answers behind similar-looking research products.
A reassuring scan does not always resolve persistent knee symptoms. What that means for recovery—and what the limited human evidence can …
In a 170-person randomized trial of difficult diabetic foot ulcers, 42% of wounds closed with a collagen-PHMB matrix plus standard care, …
A 24-man randomized crossover study found NAC helped muscle repair in participants with low muscle glutathione but impaired repair in tho…
Soreness, restored strength, tissue repair and muscle growth are different goals. Read hot- and cold-water recovery studies with that dis…
Rubedo reports a lower skin-aging clock score in 11 paired samples after experimental RLS-1496 cream. Clinical rejuvenation remains unpro…
A British cohort offers hope about later health markers after midlife weight loss. Its findings deserve a careful reading, without promis…
What happens when GLP-1 treatment ends? Compare withdrawal trials, exercise follow-up and the limits of evidence about keeping weight off.
A human wound-healing program shows both the promise and the difficulty of translating LL-37 biology into treatment. It also shows why an…
The experimental gene therapy borrows tools that can reset a cell’s identity. Its more delicate goal is to recover function without makin…
An October 2026 randomized trial reported fibrosis improvement with dasatinib plus quercetin in MASH. The biopsy signal is promising but …
An October 2026 Immunity study compares immune-cell patterns in 2,609 people. Learn why the granzyme K/B ratio is promising but not a cli…
Why Bonn’s slow blood-to-neural-stem-cell conversion may help aging research, and why a younger molecular clock is not proof of human rej…